Skip to main content

EBOS Group Limited (EBOSY)

OTC Markets (US) Healthcare Medical - SpecialtiesView data quality →
58.6Fair

ValueMarkers Composite Index

Top 74%#11,663 of 44,707
Undervalued

86% below intrinsic value ($167)

UndervaluedFair ValueOvervalued
Piotroski
5/9
Neutral
Beneish
-2.11
Investigate
Altman
2.29
Grey Zone
DCF Value
$167
Undervalued
ROIC
5.7%
Low
P/E
13.0
Value
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

EBOS Group Limited (EBOSY) — VMCI valuation read

EBOSY prints VMCI 59/100 inside the Healthcare sector, where the median sits at 50. The 9-point above-median delta is the cleanest single-number summary of EBOS Group Limited's composite stance, and in the mid-cap bucket it places the share ahead of the typical peer on the five-pillar mix.

On EBOSY, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.

**Investor frame.** EBOSY trades at 22.0x earnings, 22% above the Healthcare median of 18.0x; that is the value line. ROIC of 18.0% sits 8.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of -0.8x leaves covenant headroom; that is the risk line for EBOS Group Limited on the trailing financials.

EBOSY rose 0.8% over the trailing 7 days, with a -4.7% read on a 30-day basis.

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company supplies health and wellness products to public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and provides pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers allografts solutions; healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.

CEO: Adam Luke Hall5,200 employeesAUwww.ebosgroup.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in EBOSY’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.